Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy.
Leahy AB, Devine KJ, Li Y, Liu H, Myers R, DiNofia A, Wray L, Rheingold SR, Callahan C, Baniewicz D, Patino M, Newman H, Hunger SP, Grupp SA, Barrett DM, Maude SL.
Leahy AB, et al.
Blood. 2022 Apr 7;139(14):2173-2185. doi: 10.1182/blood.2021012727.
Blood. 2022.
PMID: 34871373
Free PMC article.